BCBSM/BCN Dual Header The Record Header Logo

The Record - Insurance Card with the BCBSM/BCN Cross and Shield logo that reads, Blue Cross Blue Shield, Blue Care Network of Michigan. Tagline: Confidence comes with every card. Image of Note boards with paper that has the letters RX on it accompanied by a stethoscope

Forward to a friend  |  Subscribe  |  The Record Archive  |  Contacts  |  bcbsm.com  |  Print this article

January 2018

We’re requiring prior authorization for some additional specialty drugs for MA PPO members

Additional specialty medications covered under the Medicare Part B medical benefit for Medicare Advantage PPO members will require prior authorization, beginning with dates of service on or after Feb. 12, 2018. These are medications that aren’t self-administered, but must be given by injection or infusion by a doctor or health care professional in the office setting.

The prior authorization requirement helps ensure that health care providers use the most effective therapies available, according to the Centers for Medicare & Medicaid Services coverage guidelines for medical necessity, safety and efficacy.

Doctors must obtain prior authorization and verify patient benefits to be eligible for payment for administering these services. Doctors can submit a request and obtain authorization within 90 days of the date of service. If prior authorization isn’t obtained, the claim will be denied.

Keep in mind that the patient must meet all the requirements and have the necessary coverage for the claim to be paid. Also, authorization isn’t a guarantee of payment. CMS benefit coverage rules and exclusions or limitations apply.

What specialty medications require prior authorization?
Listed below are the specialty drugs that have been added to the list for Medicare Part B prior authorization effective for dates of service on or after Feb. 12, 2018:

HCPCS code Brand name

J2357

Xolair®

J2786

Cinqair®

J2182

Nucala®

J3590

Ocrevus®

J0202

Lemtrada®

J3490

Spinraza®

J9299

Opdivo®

J9271

Keytruda®

Our prior authorization program is evaluated on an ongoing basis, and we may add or remove drugs or procedures from our list of drugs that require prior authorization. When this happens, we’ll notify you through The Record or web-DENIS.

How do I initiate a prior authorization request?

See the July 2017 Record article for details.

No portion of this publication may be copied without the express written permission of Blue Cross Blue Shield of Michigan, except that BCBSM participating health care providers may make copies for their personal use. In no event may any portion of this publication be copied or reprinted and used for commercial purposes by any party other than BCBSM. *CPT codes, descriptions and two-digit numeric modifiers only are copyright 2017 American Medical Association. All rights reserved.